MarketCap
Facebook
X
TelegramCantel Medical Corp. General and Administrative Expenses 2011-2025 | CMD
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Cantel Medical Corp.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 198 M | 172 M | 138 M | 122 M | 97.5 M | 77.9 M | 65 M | 53.2 M | 47.6 M | 40.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 198 M | 40.7 M | 101 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
40.5 M | $ 24.39 | - | $ 1.12 B |  USA |
 |
Baxter International
BAX
|
2.97 B | $ 19.68 | 2.77 % | $ 10 B | USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 200.26 | -0.34 % | $ 57.6 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.79 M | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Harvard Bioscience
HBIO
|
22.8 M | $ 0.71 | -3.6 % | $ 30.1 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
639 M | $ 147.79 | -0.43 % | $ 3.6 B | USA |
 |
Alcon
ALC
|
251 M | $ 79.23 | 0.53 % | $ 40.4 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
419 M | $ 171.52 | 1.59 % | $ 5.35 B | USA |
 |
AtriCure
ATRC
|
291 M | $ 41.41 | -2.29 % | $ 1.94 B | USA |
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
27.2 M | $ 4.8 | 1.05 % | $ 26.5 K | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 5.8 | 0.35 % | $ 264 M | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 13.38 | 1.83 % | $ 547 M | USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 81.12 | -1.17 % | $ 16.2 B | USA |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 83.58 | -0.5 % | $ 1.88 B | USA |
 |
Glaukos Corporation
GKOS
|
224 M | $ 111.86 | 2.72 % | $ 5.42 B | USA |
 |
Haemonetics Corporation
HAE
|
437 M | $ 78.81 | -5.6 % | $ 3.97 B | USA |
 |
InfuSystem Holdings
INFU
|
46.1 M | $ 9.18 | -0.65 % | $ 190 M | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 136.6 | -1.25 % | $ 7.28 B | USA |
 |
Isoray
ISR
|
26.6 M | - | 0.03 % | $ 108 M | USA |
 |
Merit Medical Systems
MMSI
|
400 M | $ 85.98 | -0.83 % | $ 5.01 B | USA |
 |
Intuitive Surgical
ISRG
|
2.14 B | $ 554.57 | 2.26 % | $ 197 B | USA |
 |
OraSure Technologies
OSUR
|
46.2 M | $ 2.48 | -0.25 % | $ 185 M | USA |
 |
Microbot Medical
MBOT
|
4.13 M | $ 2.25 | -6.64 % | $ 22.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
12.3 M | $ 0.37 | -5.12 % | $ 29.5 M | USA |
 |
Nephros
NEPH
|
8.91 M | $ 4.96 | -1.29 % | $ 51.5 M | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 22.01 | 0.16 % | $ 3.79 B | USA |
 |
ResMed
RMD
|
739 M | $ 252.48 | 0.05 % | $ 36.9 B | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 42.14 | -2.86 % | $ 139 M | USA |
 |
STAAR Surgical Company
STAA
|
89.9 M | $ 23.59 | -2.24 % | $ 1.16 B | USA |
 |
STERIS plc
STE
|
1.33 B | $ 252.72 | 0.32 % | $ 24.9 B | USA |
 |
Stereotaxis
STXS
|
14 M | $ 2.36 | -0.42 % | $ 190 M | USA |
 |
Pulse Biosciences
PLSE
|
15.8 M | $ 14.04 | -1.44 % | $ 674 M | USA |
 |
Predictive Oncology
POAI
|
7.42 M | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
219 M | $ 158.66 | 0.81 % | $ 8.84 M | USA |
 |
Utah Medical Products
UTMD
|
11 M | $ 58.21 | 0.19 % | $ 211 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.6 B | $ 11.38 | -1.69 % | $ 2.31 B | USA |
 |
Retractable Technologies
RVP
|
13.6 M | $ 0.84 | 2.04 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
995 M | $ 126.36 | -0.24 % | $ 5.92 B | USA |
 |
West Pharmaceutical Services
WST
|
338 M | $ 270.21 | 0.99 % | $ 19.7 B | USA |